Parodi Alessia, Traverso Paolo, Kalli Francesca, Conteduca Giuseppina, Tardito Samuele, Curto Monica, Grillo Federica, Mastracci Luca, Bernardi Cinzia, Nasi Giorgia, Minaglia Francesco, Simonato Alchiede, Carmignani Giorgio, Ferrera Francesca, Fenoglio Daniela, Filaci Gilberto
Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.
Oncotarget. 2016 Feb 9;7(6):6424-35. doi: 10.18632/oncotarget.7024.
Bladder cancer has an unexplained, high recurrence rate. Causes of recurrence might include the presence of sporadic tumor micro-foci in the residual urothelial tissue after surgery associated with an inverted ratio between intratumoral effector and regulatory T cell subsets. Hence, surgical specimens of both tumors and autologous, macroscopically/histologically free-of-tumor tissues were collected from 28 and 20 patients affected by bladder or renal cancer, respectively. The frequencies of effector (IFNγ+ and IL17+ T cells) and regulatory (CD4+CD25hiCD127lo and CD8+CD28-CD127loCD39+ Treg) T cell subpopulations among tumor infiltrating lymphocytes were analyzed by immunofluorescence, while the gene expression of MAGE-A1 and MAGE-A2 tumor-associated antigens was studied by RT-PCR. The results show that both the T cell infiltrate and the frequency of MAGE-A1/A2 gene expression were comparable in tumors and in autologous free-of-tumor tissues in bladder cancer, while the autologous free-of-tumor renal tissues showed reduced T cell infiltrate and frequency of MAGE gene expression as compared to the autologous tumors. Importantly, the intra-tumor T effector/Treg cell ratio was consistently <1 in bladder cancer patients (n. 7) who relapsed within two years, while it was always >1 in patients (n. 6) without recurrence (regardless of tumor stage) (P = 0.0006, Odds ratio = 195). These unprecedented findings clarify the pathogenic mechanism of bladder cancer recurrence and suggest that microscopically undetectable micro-foci of tumor may predispose to recurrence when associated with an inverted intratumoral T effector/Treg cell ratio.
膀胱癌具有无法解释的高复发率。复发原因可能包括手术后残余尿路上皮组织中存在散发性肿瘤微灶,这与肿瘤内效应性和调节性T细胞亚群之间的倒置比例有关。因此,分别从28例膀胱癌患者和20例肾癌患者中收集肿瘤手术标本以及自体的、宏观/组织学上无肿瘤的组织。通过免疫荧光分析肿瘤浸润淋巴细胞中效应性(IFNγ+和IL17+ T细胞)和调节性(CD4+CD25hiCD127lo和CD8+CD28-CD127loCD39+ Treg)T细胞亚群的频率,同时通过RT-PCR研究MAGE-A1和MAGE-A2肿瘤相关抗原的基因表达。结果表明,在膀胱癌中,肿瘤组织和自体无肿瘤组织中的T细胞浸润以及MAGE-A1/A2基因表达频率相当,而与自体肿瘤相比,自体无肿瘤的肾组织中T细胞浸润和MAGE基因表达频率降低。重要的是,在两年内复发的膀胱癌患者(n = 7)中,肿瘤内T效应细胞/Treg细胞比值始终<1,而在无复发的患者(n = 6)中(无论肿瘤分期如何)该比值始终>1(P = 0.0006,优势比 = 195)。这些前所未有的发现阐明了膀胱癌复发的致病机制,并表明当与肿瘤内T效应细胞/Treg细胞比值倒置相关时,显微镜下不可检测的肿瘤微灶可能易导致复发。
Diagnostics (Basel). 2022-11-29
Adv Exp Med Biol. 2020
J Cancer Res Clin Oncol. 2018-12-11
Histochem Cell Biol. 2015-7
Nat Cell Biol. 2014-9-14
Cancer Immunol Immunother. 2013-1-29
Expert Opin Biol Ther. 2012-7-31